Transgenic Over Expression of Nicotinic Receptor Alpha 5, Alpha 3, and Beta 4 Subunit Genes Reduces Ethanol Intake in Mice
Transgenic Over Expression of Nicotinic Receptor Alpha 5, Alpha 3, and Beta 4 Subunit Genes Reduces Ethanol Intake in Mice Xavier Gallego1,2,*, Jessica Ruiz3, Olga Valverde3, Susanna Molas1,2, Noemí Robles4, Josefa Sabrià4, John C. Crabbe5, and Mara Dierssen1,2 1Genes and Disease Program, Centre for Genomic Regulation (CRG), UPF, Barcelona, Spain 2CIBER de Enfermedades Raras (CIBERER), CRG-UPF, Barcelona, Spain 3Neurobiology of Behavior Research Group. Department of Health and Life Experimental Sciences. Pompeu Fabra University (UPF), Barcelona, Spain 4Department of Biochemistry, Autonomous University of Barcelona (UAB), Cerdanyola del Vallès, Barcelona, Spain 5Portland Alcohol Research Center, Department of Behavioral Neuroscience, Oregon Health & Science University, VA Medical Center, Portland, Oregon 97239 USA Abstract Abuse of alcohol and smoking are extensively co-morbid. Some studies suggest partial commonality of action of alcohol and nicotine mediated through nicotinic acetylcholine receptors (nAChRs). We tested mice with transgenic over expression of the alpha 5, alpha 3, beta 4 receptor subunit genes, which lie in a cluster on human chromosome 15, that were previously shown to have increased nicotine self-administration, for several responses to ethanol. Transgenic and wild- type mice did not differ in sensitivity to several acute behavioral responses to ethanol. However, transgenic mice drank less ethanol than wild-type in a two-bottle (ethanol vs. water) preference test. These results suggest a complex role for this receptor subunit gene cluster in the modulation of ethanol’s as well as nicotine’s effects. Keywords Nicotine; ethanol; transgenic mice; nAChR subunits; preference drinking; dependence Introduction Studies in cell lines have demonstrated that nicotine and alcohol (ethanol) interact at nicotinic acetylcholine receptors (nAChRs), altering their expression levels (Dohrman and Reiter, 2003) and modulating their agonist response (Marszalec et al., 1999).
[Show full text]